cyclophosphamide,acalabrutinib,doxorubicin,rituximab
teva,sopherion,astrazeneca
['doxorubicin', 'dlbcl', 'acalabrutinib', 'lymphoma', 'cyclophosphamide', 'ritux']
prof andrew davies will be presenting at the aggressive lymphomas: prospective therapeutic trials poster session today in hall d (ernest n morial convention center) #ash22 
Experimental Cancer Medicine Centres drive development of new cancer therapies. Jointly funded @CR_UK & @NIHRresearch @CSO_Scotland @ResearchWales @BelfastTrust